The store will not work correctly when cookies are disabled.
3-(3-(4-fluorophenyl)acryloyl)-5-methyl-5-phenylimidazolidine-2,4-dione
ID: ALA261645
Chembl Id: CHEMBL261645
PubChem CID: 44450610
Max Phase: Preclinical
Molecular Formula: C19H15FN2O3
Molecular Weight: 338.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(c2ccccc2)NC(=O)N(C(=O)/C=C/c2ccc(F)cc2)C1=O
Standard InChI: InChI=1S/C19H15FN2O3/c1-19(14-5-3-2-4-6-14)17(24)22(18(25)21-19)16(23)12-9-13-7-10-15(20)11-8-13/h2-12H,1H3,(H,21,25)/b12-9+
Standard InChI Key: OIGCBHZRLIIRNL-FMIVXFBMSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 338.34 | Molecular Weight (Monoisotopic): 338.1067 | AlogP: 2.83 | #Rotatable Bonds: 3 |
Polar Surface Area: 66.48 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.24 | CX Basic pKa: | CX LogP: 3.41 | CX LogD: 3.41 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.69 | Np Likeness Score: -0.66 |
References
1. Lu Q, Peevey J, Jow F, Monaghan MM, Mendoza G, Zhang H, Wu J, Kim CY, Bicksler J, Greenblatt L, Lin SS, Childers W, Bowlby MR.. (2008) Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators)., 16 (6): [PMID:18226531] [10.1016/j.bmc.2007.12.031] |